Holen Sie sich die Stockscreener-App
14.60
3.40%
0.48
Vorhandelsmarkt:
14.72
0.12
+0.82%
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BlackRock (CLPT holder) discloses 7.1% beneficial stake in ClearPoint Neuro - Stock Titan
CLPT|Clearpoint Neuro Inc|Price:14.412|Chg%:+0.291 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.813|Chg%:+0.693 - TradingKey
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clearpoint Neuro Inc (CLPT) Balance Sheet - TradingKey
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.120|Chg%:-0.370 - TradingKey
(CLPT) Risk Channels and Responsive Allocation - Stock Traders Daily
CLPT Q1 2026 Earnings: EPS Misses Estimates, Stock Still RisesRevenue Guidance Range - dars.gov.et
ClearPoint Neuro to announce Q2 2026 results on August 3 - scanx.trade
Articles from ClearPoint Neuro, Inc. - FinancialContent
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026 - ACCESS Newswire
ClearPoint Neuro Q2 review starts Aug. 3 at 4:30 p.m. ET - Stock Titan
ClearPoint Neuro Inc. (CLPT) Q1 2026 Earnings: EPS Misses Estimates, Stock Declines Over 3%Margin Expansion Trends - dars.gov.et
EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery - Contract Pharma
ClearPoint Neuro Slips Over 3% as Shares Test Key Support LevelsWave Equality - dars.gov.et
Why I've (Reluctantly) Sold My ClearPoint Neuro Position (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (CLPT) Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Shares DipRevenue Surprise History - dars.gov.et
ClearPoint Neuro (CLPT) surges 26.0%: Is this an indication of further gains? - MSN
Form 4 Clearpoint Neuro Inc For: 6 July By Investing.com - Investing.com Canada
Director at ClearPoint Neuro (NASDAQ: CLPT) receives 222-share stock grant - Stock Titan
ClearPoint Neuro (CLPT) Holds Steady Near $18.72 as Traders Eye Key Support and Resistance LevelsLong Term Entry Picks - dars.gov.et
CLPTClearPoint Neuro Inc Volatility & Greeks - Finviz
ClearPoint Neuro outlines growth ambitions in precision neurosurgery - Ad-hoc-news.de
Form 4 Clearpoint Neuro Inc For: 2 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CBO adds 1,781 ESPP shares, now holds 110,263 - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer STIGALL L. JEREMY - Moomoo
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer D'Alessandro Danilo - Moomoo
ClearPoint Neuro (CLPT) CFO acquires 1,085 shares through ESPP - Stock Titan
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer BURNETT JOSEPH - Moomoo
Clearpoint Neuro Insider Sold Shares Worth $387,600, According to a Recent SEC Filing - marketscreener.com
ClearPoint Neuro CEO Burnett sells $387,600 in company shares By Investing.com - Investing.com Nigeria
ClearPoint Neuro CEO Burnett sells $387,600 in company shares - Investing.com
Form 4 Clearpoint Neuro Inc For: 1 July By Investing.com - Investing.com Canada
ClearPoint Neuro (CLPT) CEO exercises options and sells 20,000 shares under 10b5-1 plan - Stock Titan
Price to sales forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to book forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Price to earnings forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to EBITDA forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
(CLPT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Director sale notice, CLPT (NASDAQ: CLPT) — 20,000 shares via option exercise - Stock Titan
ClearPoint Neuro | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Enterprise value to EBIT forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
Enterprise value to revenue forward of ClearPoint Neuro Inc. – NASDAQ:CLPT - TradingView
ClearPoint Neuro, Inc. Actuals & Estimates (NASDAQ:CLPT) - TradingView
CLPT Forecast — Price Target — Prediction for 2027 - TradingView
Compared to estimates, ClearPoint Neuro (CLPT) Q1 earnings: A look at key metrics - MSN
ClearPoint Neuro, Inc. (CLPT) reports Q1 loss, lags revenue estimates - MSN
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE) - The Globe and Mail
ClearPoint Neuro (CLPT) CEO sells 61,843 shares after exercising options - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating - Moomoo
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $25 - Moomoo
0.79%
4.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):